ClinicalTrials.Veeva

Menu

Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development (MAL-ED)

F

Foundation for the National Institutes of Health

Status

Unknown

Conditions

Immune Response
Cognitive Development
Malnutrition
Diarrhea
Wasting
Stunting

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT02441426
MAL-ED-47075

Details and patient eligibility

About

Malnutrition is considered one of the most prevalent risk factors for morbidity and mortality in children under five. An estimated 20% of children in the developing world are malnourished [1] and poor nutrition is linked to more than half of all child deaths worldwide [2]. Malnutrition in early childhood may lead to cognitive and physical deficits and may cause similar deficits in future generations as malnourished mothers give birth to low birth weight children [3]. In addition, malnutrition increases susceptibility and incidence of infections and is associated with diminished response to vaccines.

The MAL-ED Project is designed to determine the impact of enteric infections/diarrhea that alter gut function and impair children's nutrition, growth and development to help develop new intervention strategies that can break the vicious enteric infection-malnutrition cycle and reduce its global burden.

The overall objective of the MAL-ED Project is to quantify the associations of specific enteric pathogens, measures of physical and mental development, micronutrient malnutrition, gut function biomarkers, the gut microbiome, and immune responses in very young children in resource-limited settings across eight sites that vary by culture, economics, geography, and climate.

The central hypothesis of the MAL-ED Project is that infection (and co-infection) with specific enteropathogens leads to impaired growth and development and to diminished immune response to orally administered vaccines by causing intestinal inflammation and/or by altering intestinal barrier and absorptive function. Data analyses will test for associations between enteropathogen infections and growth/development to help illuminate:

  • which micro-organisms or mixed infections are most frequently associated with growth faltering and poor development; and
  • at what age specific infections cause the most disruption to growth and development and impair immune response.

Enrollment

1,796 estimated patients

Sex

All

Ages

1 minute to 17 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Less than 17 days old.

Exclusion criteria

  • Mother is less than 16 years of age.
  • Mother has another child inthe MAL-ED study.
  • Pregnancy resulted in multiple birth (e.g., twins).
  • Child has a severe disease requiring hospitalization for something other than for a typical healthy birth.
  • Child has a severe or chronic condition diagnosed by a medical doctor (e.g., neonatal disease, renal disease, chronic heart failure, liver disease, cystic fibrosis, congenital conditions).
  • Child has enteropathies diagnosed by medical doctor.
  • Mother is living and unable to provide informed consent.

Trial design

1,796 participants in 8 patient groups

Bangladesh
Description:
Birth cohort study community in Bangladesh is urban, and located in the Mirpur neighborhood of Dhaka. Case control study is being conducted in the same catchment area. Cases defined as children 6-24 months of age with \<-2WAZ (weight for age) score, controls are age and community matched with \>-1WAZ.
Brazil
Description:
Birth cohort study community in Brazil is urban, and located within the Papoco area of Fortaleza. Case control study is being conducted in the same area as the cohort study. Cases are children 6 - 24 months of age, with \<-2 WAZ (weight for age) score, controls are age and community matched children with \>-1 WAZ.
India
Description:
Birth cohort study community in India is urban, and located in the southern state of Tamil Nadu, specifically in Vellore.
Nepal
Description:
Birth cohort study community in Nepal is semi-urban, and located in Bhaktapur, approximately 25km from Kathmandu.
Pakistan
Description:
Birth cohort study community in Pakistan is rural, and located in Naushero Feroze, Sindh.
Peru
Description:
Birth cohort study community in Peru is rural, and located approximately 15km from Iquitos in Loreto.
South Africa
Description:
Birth cohort study community in South Africa is rural/peri-urban, and comprised of nine settlements within Limpopo Province.
Tanzania
Description:
Birth cohort study community in Tanzania is rural, and located within Haydom.

Trial contacts and locations

8

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems